High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …

P Brice, D Simon, R Bouabdallah, C Belanger… - Annals of oncology, 2000 - Elsevier
Background Among the 566 patients with follicular lymphomas (FL) included in the GELF 86
prospective trials from October 1986 to September 1995, 372 with progressive/relapsing …

[PDF][PDF] High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …

P Brice, D Simon, R Bouabdallah, C Belanger… - Annals of …, 2000 - researchgate.net
Background: Among the 566 patients with follicular lymphomas (FL) included in the GELF 86
prospective trials from October 1986 to September 1995, 372 with progressive/relapsing …

[引用][C] High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …

P Brice, D Simon, R Bouabdallah, C Bélanger… - Annals of …, 2000 - cir.nii.ac.jp
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression
prolonged survival of follicular lymphoma patients included in the prospective GELF 86 …

High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …

P Brice, D Simon, R Bouabdallah… - Annals of Oncology …, 2000 - europepmc.org
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression
prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol …

High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …

P Brice, D Simon, R Bouabdallah, C Belanger… - Annals of …, 2000 - elibrary.ru
Background: Among the 566 patients with follicular lymphomas (FL) included in the GELF 86
prospective trials from October 1986 to September 1995, 372 with progressive/relapsing …

High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …

P Brice, D Simon, R Bouabdallah, C Bélanger… - Annals of …, 2000 - hero.epa.gov
BACKGROUND: Among the 566 patients with follicular lymphomas (FL) included in the
GELF 86 prospective trials from October 1986 to September 1995, 372 with …

High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …

P Brice, D Simon, R Bouabdallah… - Annals of oncology …, 2000 - pubmed.ncbi.nlm.nih.gov
Background Among the 566 patients with follicular lymphomas (FL) included in the GELF 86
prospective trials from October 1986 to September 1995, 372 with progressive/relapsing …

High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …

P Brice, D Simon, R Bouabdallah, C Belanger… - Annals of …, 2000 - dial.uclouvain.be
Background: Among the 566 patients with follicular lymphomas (FL) included in the GELF 86
prospective trials from October 1986 to September 1995, 372 with progressive/relapsing …

[引用][C] High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …

P BRICE, D SIMON, N BROUSSE… - Annals of …, 2000 - pascal-francis.inist.fr
High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression
prolonged survival of follicular lymphoma patients included in the prospective GELF 86 …

High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …

P Brice, D Simon, R Bouabdallah… - Annals of …, 2000 - annalsofoncology.org
Background Among the 566 patients with follicular lymphomas (FL) included in the GELF 86
prospective trials from October 1986 to September 1995, 372 with progressive/relapsing …